Sign up to save your podcasts
Or
Share Why isn't the CDC intervening for needle fear?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Why isn't the CDC intervening for needle fear?
Dr. Baxter talks about new data on pediatric vaccination efficacy, the impact of strains going forward, and she gives an update on her nasal irrigation study.
Find Buzzy & VibraCool at shop.paincarelabs.com
Dedicated COVID-19 webpage here:
https://explore.paincarelabs.com/covid-19-vaccination-resources
Buzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections, and the temporary relief of minor injuries (muscle or tendon aches, splinters, and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion, and muscle tension.
Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.
View all episodes
By Pain Care Labs
5
44 ratings
Dr. Baxter talks about new data on pediatric vaccination efficacy, the impact of strains going forward, and she gives an update on her nasal irrigation study.
Find Buzzy & VibraCool at shop.paincarelabs.com
Dedicated COVID-19 webpage here:
https://explore.paincarelabs.com/covid-19-vaccination-resources
Buzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections, and the temporary relief of minor injuries (muscle or tendon aches, splinters, and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion, and muscle tension.
Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.